J. B. Chemicals & Pharmaceuticals
NSE: JBCHEPHARM
₹2,416.10+7.20 (+0.30%)
Thursday 16 July, 15:29 IST. Delayed. Source: Yahoo Finance.
Price chart
This chart is unavailable right now.
The day
- Previous close
- ₹2,408.90
- Open
- –
- Day high
- ₹2,525.50
- Day low
- ₹2,380.00
Key numbers
- Market value
- ₹38,793 Cr
- P/E (trailing)
- 54.22
- EPS (trailing)
- ₹44.56
- Price to book
- 9.33
- Return on equity
- 18.7%
- Debt to equity
- 0.00
- Profit margin
- 17.1%
- Beta
- 0.04
- Volume today
- 47.79 L
- Average volume
- 4.34 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹3,116.51 Cr | ₹409.84 Cr |
| FY24 | ₹3,447.67 Cr | ₹552.63 Cr |
| FY25 | ₹3,862.04 Cr | ₹659.58 Cr |
| FY26 | ₹4,076.20 Cr | ₹709.47 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
Quarterly results are unavailable from NSE right now, or none are on file for this company.
Balance sheet
The balance sheet is unavailable from NSE right now, or none is on file for this company.
About J. B. Chemicals & Pharmaceuticals
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, genecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
- Based in
- Mumbai
- Employees
- 5,602
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name J. B. Chemicals & Pharmaceuticals in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 9.30 Per Share
Dividend · ex-date 29 May 2026
- Interim Dividend - Rs 12.70 Per Share
Dividend · ex-date 11 February 2026
- Dividend - Rs 7 Per Share
Dividend · ex-date 30 July 2025
- Interim Dividend - Rs 8.50 Per Share
Dividend · ex-date 7 February 2025 · record date 8 February 2025
- Dividend - Rs 6.75 Per Share
Dividend · ex-date 14 August 2024
- Interim Dividend - Rs 5.50 Per Share
Dividend · ex-date 16 February 2024
- Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share
Split · ex-date 18 September 2023
- Dividend - Rs 9.25 Per Share
Dividend · ex-date 17 August 2023
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.